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Abstract
Aims: Recent evidence suggests that the opioid system is implicated in the patho‐
physiology of alcohol use disorder (AUD). We aimed to examine the genetic influence 
of opioid receptors on susceptibility to AUD and its clinical and psychological charac‐
teristics including harmful drinking behavior and various aspects of impulsivity in 
AUD patients.
Methods: Three μ‐opioid receptor gene (OPRM1) variants and two κ‐opioid receptor 
gene (OPRK1) variants were examined in 314 male patients with AUD and 324 male 
controls. We applied the Alcohol Use Disorders Identification Test (AUDIT), Obsessive 
Compulsive Drinking Scale (OCDS), and Alcohol Dependence Scale. AUD patients 
also completed the stop‐signal task, delay discounting task, balloon analogue risk 
task, and the Barratt Impulsiveness Scale version 11 (BIS‐11).
Results: No significant differences in genotype distributions or haplotype frequen‐
cies were found between AUD patients and controls. However, OPRK1 SNP 
rs6473797 was significantly related to the severity of alcohol‐related symptoms as 
measured by AUDIT and OCDS and a haplotype containing rs6473797 was also re‐
lated to OCDS scores in AUD patients. For other psychological traits, OPRM1 SNP 
rs495491 was significantly associated with scores on the motor subfactor of the 
BIS‐11.
Conclusion: Genetic variations in opioid receptors may contribute to symptom sever‐
ity and impulsivity in AUD patients.
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1  | INTRODUC TION
Alcohol use disorder (AUD) is a complex illness involving multiple 
genetic and environmental factors. Based on studies of twins and 
adoption, the hereditary component of alcohol dependence has 
been estimated at 50%‐60%.1 The endogenous opioid system has 
been implicated in the development of alcohol dependence due to 
its prominent role in the central reward mechanism.2 Existing studies 
suggest that the level of alcohol‐dependent activation in endoge‐
nous opioid transmission might be in part genetically determined.3 
Among opioid receptor genes, OPRM1 encoding the μ‐opioid recep‐
tor is the most intensively studied in relation to drug dependence 
and alcoholism. Several studies on the effect of single nucleotide 
polymorphisms (SNPs) in OPRM1, such as rs1799971, on alcohol 
dependence report contradictory results.4,5 Furthermore, the role 
of the κ‐opioid receptor in the regulation of reward stimuli via the 
modulation of dopaminergic tone8 has prompted research on the 
association of OPRK1 —which encodes the κ‐opioid receptor—with 
alcoholism.9 However, the role of OPRK1 in AUD is unclear due to 
conflicting results.10,11
Apart from the influence of genetic factors on the development 
of AUD, researchers have also sought to identify markers associated 
with the severity of AUD symptoms.12 However, few studies have 
explored the genetic effects of opioid receptor genes on symp‐
tom severity in AUD. In a study investigating the association of the 
OPRM1 variant rs1799971 with alcoholism severity, no significant 
results emerged from questionnaire scores.13 The μ‐opioid receptor 
is known to play a crucial role in modulating the reinforcement ef‐
fects of substances by reward circuits14; it is therefore valuable to 
investigate the link between OPRM1 and AUD severity. The OPRK1 
gene is known to be associated with levels of alcohol use in patients 
with heroin dependence undergoing methadone maintenance treat‐
ment.15 Given the absence of studies investigating the direct genetic 
influence of OPRK1 on alcohol severity in the AUD, additional re‐
search is necessary. A number of questionnaires have been designed 
to measure symptom severity in AUD; the Alcohol Use Disorders 
Identification Test (AUDIT) is considered a useful tool to identify 
harmful drinking.16 The Alcohol Dependence Scale (ADS) is one of 
the most broadly used instruments to assess the severity of alco‐
hol dependence,17 and the Obsessive Compulsive Drinking Scale 
(OCDS) has been widely used to measure the severity of cravings.18
Previous studies in humans have established that impulsivity 
is closely related to alcohol problems.19 Impulsivity as measured in 
prospective studies has been shown to predict the development of 
AUD20 and to mediate the relationship between parental substance‐
use disorders and the eventual development of substance‐use dis‐
orders in offspring.21 There is growing consensus that impulsivity 
is heterogeneous, involving a variety of behaviors and processes. 
The Barratt Impulsiveness Scale (BIS) is a well‐validated self‐report 
questionnaire that measures multidimensional impulsivity consist‐
ing of motor, attentional (cognitive), and nonplanning impulsivity.22 
Several behavioral tasks have also been developed and used for per‐
formance‐based measurement of impulsivity. In terms of behavioral 
disinhibition, the stop‐signal task (SST) is commonly used; in a previ‐
ous study using SST, the patients with alcohol dependence showed 
impaired inhibitory control.23 The delay discounting task (DDT) is 
a well‐known modality to assess the tendency to discount future 
rewards in relation to impulsive decision making.24 In relatively re‐
cent years, poor outcomes resulting from risky behavior have been 
considered an important factor in impulsivity; the Balloon Analogue 
Risk Task (BART) is being used to measure the dimension of risk‐tak‐
ing propensity.25 It is important to understand the role of impulsiv‐
ity in AUD by comprehensively considering the various dimensions 
of impulsivity using self‐rating measures and various performance 
results. From the perspective of linkage in impulsivity and opioid 
receptor genes, the OPRM1 variant rs1799971 has shown associa‐
tion with impulsivity26; moreover, OPRM1 ‐knockout mice exhibited 
a marked reduction in motor impulsivity.27 In addition, the occur‐
rence of impulsivity in patients with Parkinson's disease receiving 
dopamine replacement therapy is known to be related to OPRK1 
genotypes28; however, evidence of a relationship between opioid 
receptor genes and impulsivity is still lacking.
The aim of our study was to investigate the potential role of OPRM1 
and OPRK1 in susceptibility to AUD, as well as in its symptom severity 
characteristics using AUDIT, OCDS, and ADS in a Korean population. 
In addition, we explored the association between multidimensional 
impulsivity and OPRM1 and OPRK1 using questionnaires, BIS‐11, and 
behavioral tasks including SST, DDT, and BART in patients with AUD. 
We hypothesize that opioid receptor gene polymorphisms are associ‐
ated with symptom severity and impulsivity in AUD patients.
2  | METHODS
2.1 | Subjects
The present study included only Korean males. The patient group 
consisted of 314 patients with AUD who were hospitalized at the 
16 psychiatric hospitals throughout Korea. They were all diagnosed 
as having alcohol dependence by trained psychiatrists according 
to the Diagnostic and Statistical Manual of Mental Disorders, 4th 
Edition (DSM‐IV) criteria and had been abstinent for at least one 
week. All subjects scored above the cutoff score of 8 on the AUDIT, 
which is indicative of hazardous drinking.29 Exclusion criteria were 
as follows: (a) physical or mental illness that would interfere with 
task performance; (b) history of major psychiatric disorder includ‐
ing schizophrenia and other psychotic disorders, mood disorders, 
or anxiety disorders; (c) history of other substance dependence in 
the last 6 months; and (d) a score of less than 26 on the MMSE‐K 
(Mini‐Mental State Examination—Korean version). For the control 
group, a total of 324 nonalcoholic healthy males were enrolled from 
the Cardiovascular Genome Center at Yonsei University College of 
Medicine in the Republic of Korea between November 2000 and 
March 2011. They visited Severance Hospital, Yonsei University 
Health System, for health check‐ups. They did not have any specific 
medical conditions. Participants provided written informed consent 
according to the procedures approved by the Severance Hospital 
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Institutional Review Board, and all methods were carried out in ac‐
cordance with the approved guidelines.
2.2 | Measurements
2.2.1 | Questionnaires
The severity of symptoms in patients with AUD was assessed using 
AUDIT,16 OCDS,18 and ADS.17 The AUDIT consists of questions 
regarding alcohol consumption and the resulting consequences of 
drinking, with higher scores designating more harmful drinking be‐
havior. The OCDS assesses the efforts and ability to resist thoughts 
of alcohol and the impulse to drink, with higher scores indicating 
higher craving intensities. ADS evaluates self‐administered compul‐
sive drinking, problematic drinking behavior, and alcohol withdrawal 
symptoms. The severity of depressive and anxiety symptoms was 
assessed using the Beck Depression Inventory (BDI)30 and Beck 
Anxiety Inventory (BAI).31 All questionnaires were translated into 
Korean versions. Impulsivity was measured using the Korean version 
of the BIS‐11 for which we analyzed total scores as well as three sub‐
factors including motor, cognitive, and nonplanning scores.32
2.2.2 | Behavior tasks
We conducted the SST to assess the response inhibition and stop‐
signal reaction time (SSRT). A longer SSRT value indicates a slower 
inhibitory response. To assess the impulsivity in a choice situa‐
tion, the DDT was performed by participants. We calculated the k 
value, with higher k values designating higher sensitivity to delayed 
rewards. Lastly, the BART was conducted to measure risk‐taking 
propensity (a value of BART). A larger adjusted value of BART rep‐
resents a higher risk‐taking propensity. (See the Appendix S1 for de‐
tails of the behavior tasks.).
2.3 | SNP selection and genotyping
We selected a total of six SNPs including four OPRM1 gene SNPs 
(rs1799971, rs495491, rs609148, and rs648893) and two OPRK1 
gene SNPs (rs6473797 and rs702764). In selecting the SNPs, we re‐
viewed previous genetic studies on alcohol dependence and verified 
significant association with alcohol use based on SNP or haplotype 
analyses4,6,11,33,34 (Table S1). The minor allele frequency for each se‐
lected SNP was confirmed to be >0.05 in East Asian populations, 
based on the 1000 genomes project database (https://www.ncbi.
nlm.nih.gov/variation/tools/1000genomes/; GRCh37.p13, Phase 
3). Genomic DNA was extracted from blood. Genotyping was con‐
ducted using a single‐base primer extension assay (ABI PRISM® 
SNaPshot™ Multiplex kit; ABI/Life Technologies/Thermo Fisher 
Scientific) according to the manufacturer's instructions.
2.4 | Statistical analyses
Statistical analyses were performed using descriptive statis‐
tics for the demographic variables. Genotypes for rs609148 
and rs648893 were perfectly linked; therefore, we dropped 
rs648893 from the analyses and the allele frequencies and as‐
sociation of traits for rs609148 were extended to rs648893. 
Differences in the allelic distribution of the five SNPs were ex‐
amined using chi‐square tests. Associations between each SNP 
genotype and alcohol dependence status were examined using 
age‐adjusted multivariate logistic regression analysis. Linear 
regression models were used to evaluate associations between 
genotypes and various clinical measures of alcohol severity 
(AUDIT, OCDS, ADS) and impulsivity (BIS, SST, DDT, BART) in 
AUD subjects. Single‐marker analysis was conducted using the 
R package SNPassoc.36 We set the statistical significance level 
at P < 0.01 with Bonferroni correction for multiple comparisons 
(five SNPs). For the haplotype analysis, the pairwise linkage dis‐
equilibrium (LD) pattern of the OPRM1 and OPRK1 SNPs was 
estimated using Haploview v4.0 (http://www.broadinstitute.
org/haploview/haploview)37 and haplotype blocks were deter‐
mined from the solid spine of LD. The regression analysis of the 
TA B L E  1   Sociodemographic and clinical characteristics and 
behavioral results of the study samples
Variables AUD (n = 314)a 
Controls 
(n = 324)a  P‐value
Age, y 48.5 ± 7.79 62.3 ± 10.0 <0.001
Education, y 13.5 ± 3.96   
Age of first 
drinking
19.4 ± 6.77   
Duration of AUD, 
y
17.5 ± 10.4   
AUDIT 26.7 ± 7.70   
OCDS 19.2 ± 7.29   
ADS 21.3 ± 10.5   
BIS
Total 51.1 ± 11.0   
Cognitive 14.5 ± 3.27   
Motor 15.8 ± 4.47   
Nonplanning 20.7 ± 4.64   
BDI 18.9 ± 12.5   
BAI 13.5 ± 11.3   
Behavioral task
SSRT (n = 286) 184 ± 125   
DDT (k value) 
(n = 285)
−3.41 ± 3.14   
BART (n = 279) 9.16 ± 34.4   
Note. ADS, Alcohol‐Dependent Scale; AUD, alcohol use disorder; 
AUDIT, Alcohol Use Disorders Identification Test; BAI, Beck Anxiety 
Inventory; BART, Balloon Analogue Risk Task; BDI, Beck Depression 
Inventory; BIS, Barratt Impulsiveness Scale; DDT, delayed discount test; 
OCDS, Obsessive Compulsive Drinking Scale; SSRT, stop‐signal reaction 
time.
aMean ± standard deviation. 
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haplotypes was conducted using the “haplo.score” function of 
the program “haplo.stats” (http://cran.r‐project.org/src/contrib/
Descriptions/haplo.stats.html).38 The linear regression analysis 
of SNPs and haplotypes was conducted with adjustments for 
age, total BDI score, and total BAI score. The haplotypes with 
frequencies <0.5% were excluded. For haplotype analyses, per‐
mutation adjustments were performed (n = 10 000) and simu‐
lated P < 0.05 was regarded statistically significant.
3  | RESULTS
3.1 | Sociodemographic and clinical characteristics
The sociodemographic and clinical characteristics as well as the be‐
havioral task results of AUD patients and controls are presented in 
Table 1. All subjects were Korean males. Patients with AUD were sig‐
nificantly younger than the controls (t = 19.5, P < 0.001); therefore, 
we adjusted for age in subsequent analyses. All participants including 
AUD patients and controls were male.
3.2 | Association between OPRM1/OPRK1 SNPs and 
AUD status
There was no significant deviation from Hardy‐Weinberg equilibrium 
in the SNP data for controls, and the minor allele frequencies were 
>0.05 for all SNPs (Table S2). Comparison of allele and genotype dis‐
tributions did not reveal significant differences between AUD cases 
and normal controls for all SNPs (Table 2). Two haplotype blocks 
were each revealed for OPRM1 (rs1799971, rs495491, rs609148) 
and OPRK1 (rs702764, rs6473797; Figure 1). The results of haplo‐
type analysis revealed no significant differences in haplotype fre‐
quencies between patients with AUD and controls (Table S3).
3.3 | Influences of OPRM1/OPRK1 SNPs on 
severity of AUD
No OPRM1 SNPs or haplotypes were related to any AUDIT, OCDS, 
and ADS scores. In contrast, OPRK1 SNP rs6473797 was significantly 
related to the severity of alcohol‐related symptoms, as measured by 
the AUDIT (P = 0.0086) and OCDS (P = 0.0005; Table 3). ADS was 
not significantly related to rs6473797 (P = 0.0189) after adjusting 
for multiple comparisons. A haplotype containing rs6473797 (block 
1, rs6473797‐rs702764) was related to the OCDS scores. The A‐A 
haplotype was significantly associated with lower OCDS scores 
(Hap‐score = −3.45, simulated [sim] P = 5e‐4), and the G‐A haplo‐
type was associated with higher OCDS scores (Hap‐score = 2.60, 
sim P = 0.0088; Table 4). However, rs702764 was not significantly 
related to any symptom severity scores and haplotype block 1 was 
not significantly related to AUDIT and ADS scores (Table S4).
3.4 | Association between OPRM1/OPRK1 SNPs and 
impulsivity in AUD patients
Only rs495491 showed significant association with the motor sub‐
factor score of BIS (Table 5), while other SNPs were not significantly 
related to either total scores or subfactor scores of BIS. The results 
of the SNP analysis showed no significant association between 
OPRM1/OPRK1 SNPs and SSRT calculated from the SST and k values 
from the DDT and BART representing multidimensional impulsiv‐
ity (Table 6). No haplotypes were related to BIS total and subfactor 
scores or behavioral task results (Table S5).
4  | DISCUSSION
This study investigated the associations between five SNPs of the 
opioid receptor genes OPRM1 and OPRK1 and the affected status of 
several aspects of alcohol symptom severity and impulsivity related 
to AUD in Korean male subjects.
There was no significant difference between single‐marker or 
haplotype distributions of OPRM1 or OPRK1 and AUD status. The 
rs1799971 variant of OPRM1 has been the most frequently studied 
SNP for its association with alcohol dependence, though results 
have been inconsistent. Certain studies reported a significant as‐
sociation between rs1799971 and alcohol dependence,4,6,33 while 
others reported no genetic effect for this SNP.5,7,39 The most recent 
TA B L E  2   Distribution of allelic and genotypic frequencies of target SNPs between AUD and controls
Gene rs number
Allele Genotype
D/da  AUDb  Controlb  P‐valuec  AUDd  Controld  OR add (95% CI) P‐valuee 
OPRM1 rs1799971 A/G 394/230 396/250 0.499 125/144/43 127/142/54 0.86 (0.64‐1.14) 0.288
OPRM1 rs495491 A/G 532/92 559/89 0.607 226/80/6 245/69/10 1.20 (0.80‐1.79) 0.372
OPRM1 rs609148 G/A 582/40 595/49 0.413 272/38/1 273/49/0 0.89 (0.50‐1.56) 0.675
OPRK1 rs6473797 A/G 385/239 418/226 0.236 114/157/41 128/162/32 1.05 (0.78‐1.43) 0.746
OPRK1 rs702764 A/G 582/40 605/41 0.951 274/34/3 283/39/1 1.03 (0.59‐1.79) 0.931
Note. AUD, alcohol use disorder; Cl, confidence interval; OR, odds ratio; add, additive; SNP, single nucleotide polymorphism.
aLowercase d denotes the less frequent allele. 
bNumber of major and minor alleles in individuals with AUD and controls. 
cP‐values by Pearson's chi‐square test for allelic associations. 
dNumber of genotypes in individuals with AUD and controls. Order of genotypes: DD/Dd/dd (d is the minor allele). 
eP‐values by multivariate logistic regression with adjustment for age. 
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meta‐analysis reviewing 17 case‐control studies including nine 
Caucasian studies (8026 patients in total) and eight Asian studies 
(1587 patients in total) concluded that rs1799971 exhibited no asso‐
ciation with alcohol dependence in either ethnicity.40 For the other 
OPRM1 SNPs we investigated, rs495491 and rs609148, a study 
among 382 European American patients with alcohol dependency 
showed the genetic risk effect of the rs495491‐C minor allele and 
the protective effect of the rs609148‐T minor allele toward alco‐
hol dependence.35 However, a subsequent family‐based study with 
1923 European American samples did not find any association with 
OPRM1 SNPs including rs495491 and rs609148.41 The results of our 
study demonstrating a lack of association correspond with these 
previous studies. Although few studies exist on the association be‐
tween OPRK1 and AUD, those that have been conducted report in‐
consistent findings. A multicenter study with a family‐based design 
suggested a significant association of OPRK1 SNP rs6473797 with 
alcohol dependence.11 However, other studies showed negative 
results for the genetic effect of OPRK1 in alcoholism, contrary to 
ours.10,34,39
Although we were unable to find any association between 
OPRM1 or OPRK1 and the development of AUD, there were several 
significant associations of OPRK1 genetic variants with AUDIT and 
OCDS scores. The minor G allele of rs6473797 was associated with 
higher AUDIT scores, signifying that the AUD patients with the G 
allele showed higher hazardous drinking tendencies. In addition, 
the G allele of rs6473797 was also related to higher OCDS scores, 
suggesting more severe craving symptoms. Furthermore, in haplo‐
type block 1 of the OPRK1 gene, the G‐A haplotype of rs6473797‐
rs702764 showed higher OCDS scores, while the A‐A haplotype 
presented significantly lower scores. This result suggests that the 
rs6473797 SNP and haplotype rs6473797‐rs702764 of OPRK1 play 
a role in regulating the severity of craving related to obsessive‐
compulsive drinking in AUD. Although it did not reach statistical 
significance after correction for multiple comparisons, rs6473797 
showed nominally significant association (P = 0.0189) with ADS. 
The G allele was linked to increasing ADS scores, indicating heavier 
drinking and severe withdrawal symptoms.42 This tendency for the 
G allele of rs6473797 to be associated with higher symptom sever‐
ity in ADS is consistent with the results of the AUDIT and OCDS. 
In summary, our results suggest that the AUD patients carrying the 
G allele of OPRK1 SNP rs6473797 show more harmful drinking be‐
havior, cravings, and withdrawal symptoms, corresponding to the 
F I G U R E  1   Schematic representation of the μ‐ and κ‐opioid receptor gene with the location of the SNPs analyzed in the present study, 
and linkage disequilibrium (LD) structure among the SNPs in healthy controls. The grey boxes indicate exons in the OPRM1 and OPRK1 
genes. Haplotype blocks and LD structure were derived using Haploview version 4.2. In the haplotype blocks, pairwise D′ values and R‐
squared values were presented in squares
TA B L E  3   The effects of OPRM1 SNPs and OPRK1 SNPs on severity of alcohol use disorder
rs number D/da  DD/Dd/ddb 
AUDIT OCDS ADS
DDc  Ddc  ddc 
Mean difference 
(95% CI) Pd  DDc  Ddc  ddc 
Mean difference 
(95% CI) Pd  DDc  Ddc  ddc 
Mean difference 
(95% CI) Pd 
rs1799971 A/G 125/144/43 26.7 ± 0.71 26.4 ± 0.64 28.0 ± 1.04 0.603 (−0.54, 1.75) 0.304 19.2 ± 0.69 18.9 ± 0.59 20.4 ± 0.99 0.641 (−0.37, 1.65) 0.215 21.3 ± 0.98 20.3 ± 0.85 24.1 ± 1.45 1.01 (−0.49, 2.51) 0.188
rs495491 A/G 226/80/6 26.7 ± 0.51 26.7 ± 0.90 27.2 ± 2.28 −0.756 (−2.36, 0.84) 0.355 19.0 ± 0.46 19.6 ± 0.94 22.2 ± 2.17 −0.236 (−1.65, 1.18) 0.744 21.4 ± 0.69 20.9 ± 1.21 22.3 ± 4.81 −1.44 (−3.53, 0.65) 0.177
rs609148 G/A 272/38/1 26.7 ± 0.46 26.6 ± 1.34 36.0 ± 0.00 −0.695 (−3.00, 1.61) 0.555 19.2 ± 0.43 19.2 ± 1.37 31.0 ± 0.00 −0.691 (−2.72, 1.34) 0.505 21.3 ± 0.63 21.0 ± 1.81 41.0 ± 0.00 −0.970 (−3.98, 2.04) 0.528
rs6473797 A/G 114/157/41 25.2 ± 0.70 27.4 ± 0.60 28.6 ± 1.31 1.58 (0.41, 2.75) 0.0086 17.3 ± 0.64 20.1 ± 0.58 21.3 ± 1.18 1.85 (0.83, 2.87) 0.0005 19.6 ± 0.94 21.7 ± 0.83 24.4 ± 1.77 1.85 (0.31, 3.38) 0.019
rs702764 A/G 274/34/3 26.5 ± 0.46 28.7 ± 1.28 26.3 ± 8.84 1.08 (−1.09, 3.24) 0.331 18.9 ± 0.44 22.0 ± 1.23 20.3 ± 6.69 1.84 (−0.07, 3.74) 0.06 21.0 ± 0.63 23.6 ± 1.88 22.7 ± 7.88 1.33 (−1.51, 4.18) 0.358
Note. ADS, Alcohol‐Dependent Scale; AUDIT, Alcohol Use Disorders Identification Test; CI, confidence interval; OCDS, Obsessive Compulsive  
Drinking Scale; SNP, single nucleotide polymorphism. Bold values indicate statistical significance at the P < 0.01 level.
aLowercase d denotes the less frequent allele. 
bNumber of genotypes. 
cMean ± standard error. 
dP‐values by multivariate linear regression with adjustment for age, Beck Depression Inventory score and Beck Anxiety Inventory score. 
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experience of more painful symptoms in AUD patients. To date, 
there have been few studies on the OPRK1 gene and alcohol sever‐
ity. However, several animal and human studies indirectly suggest 
the association between the OPRK1 gene and alcohol severity. In 
animal studies, OPRK1 ‐knockout mice showed decreased oral al‐
cohol consumption.43 In an alcohol‐dependent rat model, increased 
κ‐opioid receptor signaling caused excessive alcohol consumption 
during withdrawal.44 In humans, the T‐T‐C‐T haplotype (rs7832417‐
rs16918853‐rs702764‐rs7817710) of the OPRK1 gene showed a re‐
lationship with elevated levels of alcohol use in heroin‐dependent 
patients.15 Regarding OPRM1, there were no associations between 
any of the SNPs or haplotypes and AUDIT, OCDS, and ADS scores 
in our study. Previous studies on the influences of OPRM1 SNPs on 
AUDIT or ADS also reported no associations.13,45 Considering these 
results in conjunction with ours, it seems that OPRM1 is not related 
to the severity in drinking levels or frequency that lead to harmful 
consequences in AUD.
With respect to impulsivity, we initially hypothesized that μ‐ and 
κ‐opioid receptor genes influence multidimensional impulsivity as 
measured by SST, DDT, BART, and self‐report questionnaire BIS‐11 
in AUD patients. In the μ‐opioid receptor gene, we found that the G 
allele of rs495491 in the OPRM1 gene was significantly associated 
with higher motor impulsivity subfactor scores of BIS‐11. A previ‐
ous animal study suggested that OPRM1 ‐knockout mice showed 
significantly decreased motor impulsivity as measured by prema‐
ture responses on the signaled nose poke task.27 In a study involv‐
ing PET imaging of μ‐opioid receptors, impulsivity as measured by 
the NEO PI‐R (NEO Personality Inventory, Revised) showed a sig‐
nificant positive relationship with μ‐receptor binding potential in 
the right anterior cingulate and adjacent medial frontal cortex, right 
ventral basal ganglia, and basolateral area of the right amygdala, all 
of which are areas involved in the pathophysiology of substance 
abuse.46 However, the instrumental measures of impulsivity such 
as SST, DDT, and BART were not influenced by OPRM1 or OPRK1 
variants in this study.46 Courtney et al conducted a study utilizing 
functional magnetic resonance imaging while performing SST and 
explored the functional polymorphism of OPRM1 SNP rs1799971 in 
alcohol dependence.47 The author demonstrated the difference in 
functional connectivity within fronto‐striatal networks according 
to the genotype of OPRM1 SNP rs1799971; nonetheless, there was 
no significant genotypic effect on behavioral performance results 
for the SST, as indicated by our results. Regarding DDT and BART, 
most genetic studies focused on dopamine genes48,49; there have 
been no reports on the relationship between OPRM1 or OPRK1 and 
DDT or BART. A study of the association between the DRD2 Taql 
A polymorphism and BIS in alcohol‐dependent patients showed a 
significant dopamine gene effect on impulsiveness; another study 
showed that DRD2 Taql A and DRD4 VNTR polymorphisms were 
linked to DDT results.48 Despite the fact that we were unable to 
determine the association between opioid receptor gene variants 
and SST, DDT, and BART, the dopamine and opioid systems interact 
with the reward system and impulsivity in the brain 50; therefore, 
it is likely that the opioid‐related genes OPRM1 or OPRK1 are in‐
volved in impulsivity. Further studies are necessary to determine 
their influence on various measures of impulsivity.
There are several limitations in the present study. First, the sam‐
ple size was relatively small, potentially obscuring significant genetic 
associations. Second, we were unable to select all tagging SNPs cov‐
ering the entire OPRM1 and OPRK1 genes. Studies with larger sample 
sizes and greater numbers of SNPs will be needed to clearly confirm 
the function and impact of opioid receptor genes in AUD. Third, all 
participants in the present study were exclusively male. To under‐
stand the effects of genetic differences in alcohol use and impulsiv‐
ity comprehensively, it would be necessary to study both male and 
female subjects. Lastly, impulsivity using the self‐rating scale, BIS‐11, 
and behavior tasks involving SST, DDT, and BART was assessed only 
in AUD patients, not in healthy controls. We were therefore unable 
to determine the regression model containing the control group to 
define the genetic influence of OPRM1/OPRK1 on impulsivity.
In conclusion, we found no associations between selected SNPs 
or haplotypes of OPRM1 or OPRK1 genes and the development of 
AUD in Korean males. However, certain SNPs and haplotypes of 
TA B L E  3   The effects of OPRM1 SNPs and OPRK1 SNPs on severity of alcohol use disorder
rs number D/da  DD/Dd/ddb 
AUDIT OCDS ADS
DDc  Ddc  ddc 
Mean difference 
(95% CI) Pd  DDc  Ddc  ddc 
Mean difference 
(95% CI) Pd  DDc  Ddc  ddc 
Mean difference 
(95% CI) Pd 
rs1799971 A/G 125/144/43 26.7 ± 0.71 26.4 ± 0.64 28.0 ± 1.04 0.603 (−0.54, 1.75) 0.304 19.2 ± 0.69 18.9 ± 0.59 20.4 ± 0.99 0.641 (−0.37, 1.65) 0.215 21.3 ± 0.98 20.3 ± 0.85 24.1 ± 1.45 1.01 (−0.49, 2.51) 0.188
rs495491 A/G 226/80/6 26.7 ± 0.51 26.7 ± 0.90 27.2 ± 2.28 −0.756 (−2.36, 0.84) 0.355 19.0 ± 0.46 19.6 ± 0.94 22.2 ± 2.17 −0.236 (−1.65, 1.18) 0.744 21.4 ± 0.69 20.9 ± 1.21 22.3 ± 4.81 −1.44 (−3.53, 0.65) 0.177
rs609148 G/A 272/38/1 26.7 ± 0.46 26.6 ± 1.34 36.0 ± 0.00 −0.695 (−3.00, 1.61) 0.555 19.2 ± 0.43 19.2 ± 1.37 31.0 ± 0.00 −0.691 (−2.72, 1.34) 0.505 21.3 ± 0.63 21.0 ± 1.81 41.0 ± 0.00 −0.970 (−3.98, 2.04) 0.528
rs6473797 A/G 114/157/41 25.2 ± 0.70 27.4 ± 0.60 28.6 ± 1.31 1.58 (0.41, 2.75) 0.0086 17.3 ± 0.64 20.1 ± 0.58 21.3 ± 1.18 1.85 (0.83, 2.87) 0.0005 19.6 ± 0.94 21.7 ± 0.83 24.4 ± 1.77 1.85 (0.31, 3.38) 0.019
rs702764 A/G 274/34/3 26.5 ± 0.46 28.7 ± 1.28 26.3 ± 8.84 1.08 (−1.09, 3.24) 0.331 18.9 ± 0.44 22.0 ± 1.23 20.3 ± 6.69 1.84 (−0.07, 3.74) 0.06 21.0 ± 0.63 23.6 ± 1.88 22.7 ± 7.88 1.33 (−1.51, 4.18) 0.358
Note. ADS, Alcohol‐Dependent Scale; AUDIT, Alcohol Use Disorders Identification Test; CI, confidence interval; OCDS, Obsessive Compulsive  
Drinking Scale; SNP, single nucleotide polymorphism. Bold values indicate statistical significance at the P < 0.01 level.
aLowercase d denotes the less frequent allele. 
bNumber of genotypes. 
cMean ± standard error. 
dP‐values by multivariate linear regression with adjustment for age, Beck Depression Inventory score and Beck Anxiety Inventory score. 
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TA B L E  6   The effects of OPRM1 SNPs and OPRK1 SNPs on impulsivity behavioral task results
rs number D/da 
SSRT DDT (k value) BART
DD/Dd/ddb  DDc  Ddc  ddc 
Mean difference 
(95% CI) Pd  DD/Dd/ddb  DDc  Ddc  ddc 
Mean difference 
(95% CI) Pd  DD/Dd/ddb  DDc  Ddc  ddc 
Mean 
difference (95% 
CI) Pd 
rs1799971 A/G 111/127/43 168 ± 14.2 196 ± 6.87 178 ± 20.9 11.8 (−7.95, 31.6) 0.242 112/128/43 −3.33 ± 0.32 −3.45 ± 0.29 −3.56 ± 0.31 −0.08 (−0.60, 0.44) 0.761 112/125/40 30.2 ± 1.62 27.3 ± 1.45 33.2 ± 3.04 0.351 (−2.57, 
3.27)
0.814
rs495491 A/G 204/73/4 182 ± 7.19 185 ± 18.9 153 ± 27.5 −4.78 (−33.7, 24.1) 0.746 206/73/4 −3.51 ± 0.21 −3.24 ± 0.42 −1.88 ± 0.93 0.247 (−0.51, 1.00) 0.52 202/71/4 29.9 ± 1.20 28.0 ± 2.08 21.2 ± 6.24 −2.32 (−6.56, 
1.91)
0.283
rs609148 G/A 245/34/1 180 ± 7.87 192 ± 17.1 213 ± 0.00 7.09 (−33.5, 47.7) 0.732 248/33/1 −3.53 ± 0.19 −2.50 ± 0.69 −4.05 ± 0.00 0.669 (−0.40, 1.74) 0.220 244/31/1 29.1 ± 1.10 30.8 ± 3.09 21.9 ± 0.00 1.44 (−4.65, 
7.52)
0.644
rs6473797 A/G 104/141/36 195 ± 11.5 163 ± 9.95 218 ± 20.9 −2.00 (−23.0, 19.0) 0.852 106/142/35 −3.39 ± 0.33 −3.38 ± 0.25 −3.66 ± 0.50 −0.16 (−0.71, 0.39) 0.567 105/138/34 27.6 ± 1.60 30.7 ± 1.53 28.7 ± 2.78 1.37 (−1.71, 
4.44)
0.384
rs702764 A/G 248/30/2 182 ± 8.04 189 ± 9.25 165 ± 1.67 0.99 (−39.0, 41.0) 0.961 251/30/1 −3.50 ± 0.20 −2.81 ± 0.56 −2.57 ± 0.00 0.509 (−0.59, 1.61) 0.367 245/29/2 29.7 ± 1.10 26.3 ± 3.14 23.7 ± 6.21 −3.13 (−8.98, 
2.73)
0.296
Note. BART, Balloon Analogue Risk Task; CI, confidence interval; DDT, delayed discount test; SNP, single nucleotide polymorphism; SSRT,  
stop‐signal reaction time.
aLowercase d denotes the less frequent allele. 
bNumber of genotypes. 
cmean ± standard error. 
dP‐values by multivariate linear regression with adjustment for age, Beck Depression Inventory score and Beck Anxiety Inventory score. 
TA B L E  4   The effects of haplotype on OCDS score
Block Hap‐Freqa  Hap‐Scoreb  Crude Pc  Sim Pd 
OPRK1 (rs6473797‐rs702764)e 
A A  0.615 −3.45 0.0006 5e‐04
G G  0.062 1.97 0.0493 0.0505
G A  0.321 2.60 0.0093 0.0088
OPRM1 (rs495491‐rs1799971‐rs609148)f 
A A G 0.44 −0.779 0.436 0.438
G A A 0.0164 −0.665 0.506 0.508
A A A 0.0437 −0.507 0.612 0.612
G A G 0.131 −0.137 0.891 0.890
A G G 0.364 1.26 0.209 0.21
Note. OCDS, Obsessive Compulsive Drinking Scale. Bold values indicate statistical significance at the simulated P < 0.05 level.
aHap‐Freq, estimated frequency of the haplotype in the pool of all participants. 
bHap‐Score, score for the haplotype. 
cAsymptotic chi‐square P‐value. 
dSimulated P‐value. 
eGlobal‐stat = 12.5, df = 3, P = 0.0057, global simulated P = 0.0055. 
fGlobal‐stat = 1.87, df = 5, P = 0.867, global simulated P = 0.851. 
TA B L E  5   The effects of OPRM1 SNPs and OPRK1 SNPs on motor subfactor score of BIS
rs number D/da  DD/Dd/ddb  DDc  Ddc  ddc  Mean difference(95% CI) Pd 
rs1799971 A/G 125/144/43 15.9 ± 0.37 15.6 ± 0.39 16.3 ± 0.74 0.17 (−0.48, 0.82) 0.611
rs495491 A/G 226/80/6 16.1 ± 0.31 15 ± 0.44 17.3 ± 1.26 −1.20 (−2.10,−0.30) 0.0095
rs609148 G/A 272/38/1 15.8 ± 0.27 16.2 ± 0.82 19.0 ± 0.00 −0.096 (−1.40, 1.22) 0.886
rs6473797 A/G 114/157/41 15.8 ± 0.44 15.7 ± 0.34 16.3 ± 0.70 −0.055 (−0.73, 0.62) 0.873
rs702764 A/G 274/34/3 15.7 ± 0.27 16.5 ± 0.83 17.7 ± 3.53 0.485 (−0.75, 1.72) 0.44
Note. BIS, Barratt Impulsiveness Scale; CI, confidence interval; SNP, single nucleotide polymorphism. The bold value indicates statistical significance 
at the P < 0.01 level.
aLowercase d denotes the less frequent allele. 
bNumber of genotypes. 
cmean ± standard error. 
dP‐values by multivariate linear regression with adjustment for age, Beck Depression Inventory score and Beck Anxiety Inventory score. 
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OPRK1 were associated with hazardous drinking tendency (AUDIT 
scores) and craving symptoms (OCDS scores). The OPRM1 SNP 
rs495491 was related to motor impulsivity as measured by the 
BIS‐11 in patients with AUD. These findings suggest that the opioid 
receptor genes may have a modulating influence on several aspects 
of symptom severity related to AUD and impulsivity in Korean males 
with AUD.
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